{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T04:57:10Z","timestamp":1794632230625,"version":"4.9.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005075","name":"University Medical Centrer Groningen","doi-asserted-by":"publisher","award":["2014-2\/222"],"award-info":[{"award-number":["2014-2\/222"]}],"id":[{"id":"10.13039\/501100005075","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.antiviral.2018.08.006","type":"journal-article","created":{"date-parts":[[2018,8,10]],"date-time":"2018-08-10T12:22:33Z","timestamp":1533903753000},"page":"206-212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Increased incidence of herpes zoster in patients on renal replacement therapy cannot be explained by intrinsic defects of cellular or humoral immunity to varicella-zoster virus"],"prefix":"10.1016","volume":"158","author":[{"given":"Christien","family":"Rondaan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anoek A.E.","family":"de Joode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander","family":"van Assen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolaas A.","family":"Bos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Westerhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6581-6508","authenticated-orcid":false,"given":"Johanna","family":"Westra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2018.08.006_bib1","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1399-3062.2007.00289.x","article-title":"Varicella zoster virus-associated disease in adult kidney transplant recipients: incidence and risk-factor analysis","volume":"10","author":"Arness","year":"2008","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.08.006_bib2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrneph.2013.44","article-title":"Immune cell dysfunction and inflammation in end-stage renal disease","volume":"9","author":"Betjes","year":"2013","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.antiviral.2018.08.006_bib3","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1089\/aid.2010.0340","article-title":"Varicella-zoster virus-specific cell-mediated immune responses in HIV-infected adults","volume":"27","author":"De Castro","year":"2011","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.antiviral.2018.08.006_bib4","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1503\/cmaj.091711","article-title":"The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study","volume":"182","author":"Drolet","year":"2010","journal-title":"CMAJ"},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2018.08.006_bib5","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jinf.2015.04.015","article-title":"Varicella zoster virus immunity: a primer","volume":"71","author":"Duncan","year":"2015","journal-title":"J. Infect."},{"key":"10.1016\/j.antiviral.2018.08.006_bib6","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1525-139X.2007.00283.x","article-title":"Disturbances of acquired immunity in hemodialysis patients","volume":"20","author":"Eleftheriadis","year":"2007","journal-title":"Semin. Dial."},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2018.08.006_bib7","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S1386-6532(10)70002-0","article-title":"Advances in the understanding of the pathogenesis and epidemiology of herpes zoster","volume":"48","author":"Gershon","year":"2010","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2018.08.006_bib8","doi-asserted-by":"crossref","first-page":"15016","DOI":"10.1038\/nrdp.2015.16","article-title":"Varicella zoster virus infection","volume":"1","author":"Gershon","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.antiviral.2018.08.006_bib9","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1002\/art.24679","article-title":"Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus","volume":"60","author":"Holvast","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.antiviral.2018.08.006_bib10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/2051013615599151","article-title":"Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective","volume":"3","author":"Johnson","year":"2015","journal-title":"Ther. Adv. Vaccines"},{"key":"10.1016\/j.antiviral.2018.08.006_bib11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jim.2003.09.001","article-title":"Comparison of the ELISPOT and cytokine flow cytometry assays for the enumeration of antigen-specific T cells","volume":"283","author":"Karlsson","year":"2003","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.antiviral.2018.08.006_bib12","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.2215\/CJN.00950208","article-title":"Aspects of immune dysfunction in end-stage renal disease","volume":"3","author":"Kato","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.antiviral.2018.08.006_bib13","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1053\/j.ajkd.2011.10.049","article-title":"Risk of herpes zoster in patients treated with long-term hemodialysis: a matched cohort study","volume":"59","author":"Kuo","year":"2012","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.antiviral.2018.08.006_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-61779-325-7_1","article-title":"Unique strengths of ELISPOT for T cell diagnostics","volume":"792","author":"Lehmann","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.antiviral.2018.08.006_bib15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000339004","article-title":"A comparison of herpes zoster incidence across the spectrum of chronic kidney disease, dialysis and transplantation","volume":"36","author":"Lin","year":"2012","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.antiviral.2018.08.006_bib16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5414\/CNP63008","article-title":"Dysregulation of IL-2\/IL-2R system alters proliferation of early activated CD4+ T cell subset in patients with end-stage renal failure","volume":"63","author":"Meier","year":"2005","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.antiviral.2018.08.006_bib17","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1086\/644646","article-title":"Comparison of varicella-zoster virus-specific immunity of patients with diabetes mellitus and healthy individuals","volume":"200","author":"Okamoto","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.08.006_bib18","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-015-1038-1","article-title":"Incidence and risk factors of herpes zoster among adult renal transplant recipients receiving universal antiviral prophylaxis","volume":"15","author":"Pavlopoulou","year":"2015","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.08.006_bib19","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1002\/art.38804","article-title":"Altered cellular and humoral immunity to varicella-zoster virus in patients with autoimmune diseases","volume":"66","author":"Rondaan","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.antiviral.2018.08.006_bib20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jinf.2017.06.010","article-title":"Incidence of herpes zoster amongst adults varies by severity of immunosuppression","volume":"75","author":"Schroder","year":"2017","journal-title":"J. Infect."},{"key":"10.1016\/j.antiviral.2018.08.006_bib21","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000168308","article-title":"Varicella-zoster virus immune status in CAPD and chronic hemodialysis patients","volume":"11","author":"Smetana","year":"1991","journal-title":"Am. J. Nephrol."},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2018.08.006_bib22","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1002\/jmv.10318","article-title":"Measurement of cell-mediated immunity with a Varicella-Zoster Virus-specific interferon-gamma ELISPOT assay: responses in an elderly population receiving a booster immunization","volume":"70","author":"Smith","year":"2003","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2018.08.006_bib23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jcv.2012.06.008","article-title":"A community-based survey of varicella-zoster virus-specific immune responses in the elderly","volume":"55","author":"Tang","year":"2012","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2018.08.006_bib24","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/cid\/civ930","article-title":"Effectiveness of herpes zoster vaccine in patients 60 Years and older with end-stage renal disease","volume":"62","author":"Tseng","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.08.006_bib25","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1053\/j.ajkd.2012.03.018","article-title":"Risk of herpes zoster in CKD: a matched-cohort study based on administrative data","volume":"60","author":"Wu","year":"2012","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.antiviral.2018.08.006_bib26","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.09.021","article-title":"Risk of stroke in patients with herpes zoster: a systematic review and meta-analysis","volume":"26","author":"Yang","year":"2017","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.antiviral.2018.08.006_bib27","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.4065\/82.11.1341","article-title":"A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction","volume":"82","author":"Yawn","year":"2007","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.antiviral.2018.08.006_bib28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrmicro3215","article-title":"Molecular mechanisms of varicella zoster virus pathogenesis","volume":"12","author":"Zerboni","year":"2014","journal-title":"Nat. Rev. Microbiol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218302328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218302328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:30:02Z","timestamp":1759062602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354218302328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":28,"alternative-id":["S0166354218302328"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.08.006","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased incidence of herpes zoster in patients on renal replacement therapy cannot be explained by intrinsic defects of cellular or humoral immunity to varicella-zoster virus","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}